Salamander Biotech – Oral Wound Patch
Salamander Biotech Co., Ltd. is a team with more than 5 years of experience in biomedical material technology research and medical device product development. It is committed to the research and development of biomedical materials. It has been developed through the continuous challenge and innovation capabilities of the professional team. High-quality medical device products that improve health care and medical quality. Through professional knowledge and years of practical experience, the team commercializes technology and brings it into daily applications, hoping to provide better solutions for the general public and the medical system.
Salamander Biotech is a company that focuses on innovative research and development. It upholds the curiosity for experimental exploration, the enthusiasm for challenging innovation and the spirit of continuous progress to generate good ideas and good designs. We hope that through the medical treatment developed by the team Products solve various inconveniences in medical care and medical behaviors, and improve the quality of life during the care process. 👍👍👍
SMAB™ is a mucosal adhesion technology platform independently developed by Salamander Biotech Co., Ltd. It is an adhesive material technology composed of film coating technology, special double-layer structure and patented mucosal adhesion formula. SMAB™ technology can be applied to general mucosal damage and mucositis caused by chemotherapy, or can be used as a mucosal drug delivery carrier to provide solutions for different mucosal adhesion of the human body – ” Oral Wound Patch ” is a medical device license-obtained Professional intraoral wound patch brings a different choice to the public who are often troubled by mouth wounds!
Iris Zhu, deputy account manager of brand business of the cross-border business division of EZICON Group, said: “After EZICON Group’s strict global brand investment selection and product selection process, the product “Oral Wound Patch” of Salamander Biotech Co., Ltd. stood out. It is an honor to work with a team with high-quality health care concepts to make ” Oral Wound Patch ” legal across the border in the Chinese market. The product has a patented double-layer structure including a protective layer and an adhesive layer. The adhesive layer has mucoadhesive properties and can be adsorbed on any mucosal surface; the protective layer blocks stimulation from foreign objects and increases the time of mucosal adhesion! The patented film coating technology allows the double-layer structure to be as thin as paper at only 0.1 mm, effectively minimizing the foreign body sensation during use. “👏👏👏
EZICON Group is honored to join hands with Salamander Biotech Co., Ltd. to cooperate in the cross-border Chinese market to seize business opportunities in the RMB 300 billion biomedical health care consumer market, provide professional care products to the majority of consumer groups, and achieve health The ideal of zero distance across borders. 💪💪💪
–
Do you have good products?
☑#Market Assessment ☑#Channel Suggestion ☑#Integrated Marketing ☑#Buyout Sale Guarantee
Consult Now▶Your China Market Consultant↓
-Website https: https://ezicongroup.com/en/about-us/#contact
-Facebook https://www.facebook.com/messages/t/ezicongroup
-About Us ◎ https://ezicongroup.com/